Abstract

Dendritic cells (DCs) are the main mediators of Th2 immune responses in allergic asthma, and Fms-like tyrosine kinase 3 ligand (Flt3L) is an important growth factor for the development and homeostasis of DCs. This study identified the DC populations that primarily cause the initiation and development of allergic lung inflammation using Fms-like tyrosine kinase 3 (Flt3) knockout (KO) mice with allergen-induced allergic asthma. We observed type 2 allergic lung inflammation with goblet cell hyperplasia in Flt3 KO mice, despite a significant reduction in total DCs, particularly CD103+ DCs, which was barely detected. In addition, bone marrow-derived dendritic cells (BMDCs) from Flt3 KO mice directed Th2 immune responses in vitro, and the adoptive transfer of these BMDCs exacerbated allergic asthma with more marked Th2 responses than that of BMDCs from wild-type (WT) mice. Furthermore, we found that Flt3L regulated the in vitro expression of OX40 ligand (OX40L) in DCs, which is correlated with DC phenotype in in vivo models. In conclusion, we revealed that Flt3-independent CD11b+ DCs direct Th2 responses with the elevated OX40L and are the primary cause of allergic asthma. Our findings suggest that Flt3 is required to control type 2 allergic inflammation.

Highlights

  • Allergic asthma is a complex chronic inflammation of the airways characterized by airway hyperresponsiveness (AHR), goblet cell hyperplasia, epithelial hypertrophy, and mucus hypersecretion [1,2,3]

  • Serum allergen-specific IgE levels and IL-13 and OX40 ligand (OX40L) in the lung were significantly elevated in Fms-like tyrosine kinase 3 (Flt3) KO mice compared to those in WT mice

  • Mice administered OVA-bone marrow-derived dendritic cells (BMDCs) from Flt3 KO mice showed more severe allergic airway inflammation compared to those administered OVA-BMDCs from WT mice

Read more

Summary

Introduction

Allergic asthma is a complex chronic inflammation of the airways characterized by airway hyperresponsiveness (AHR), goblet cell hyperplasia, epithelial hypertrophy, and mucus hypersecretion [1,2,3]. DCs are a heterogeneous population, and various DC types contribute to the aggravation or suppression of allergic inflammation [9,12,13,14,15]. They originate from hematopoietic stem cells in the bone marrow (BM), which differentiate into macrophage DC precursors and to common dendritic cell precursors (CDPs) and common monocyte progenitors (cMoPs). CDPs develop into pre-conventional DCs (pre-cDCs) and plasmacytoid DCs (pDCs), whereas cMoPs become monocytes and monocyte-derived DCs (moDCs) [16,17]. CDC1s are preferentially affected by Flt3L levels [22]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call